Treatment of Polymicrobial Bacteremia with Enterococcus Faecalis and Staphylococcus Epidermidis
For blood cultures positive with both Enterococcus faecalis and Staphylococcus epidermidis, initiate ampicillin (if susceptible) or vancomycin (if ampicillin-resistant or methicillin-resistant S. epidermidis) as monotherapy, as both organisms will be covered by a single agent targeting the enterococcus.
Initial Antibiotic Selection
For Ampicillin-Susceptible E. Faecalis
- Ampicillin 2 g IV every 4 hours is the drug of choice for ampicillin-susceptible enterococci and will also provide coverage for methicillin-susceptible S. epidermidis 1.
- Ampicillin is preferred over other penicillins because MICs are typically two to four times lower than penicillin G for enterococcal infections 2.
- This single-agent approach covers both organisms without requiring combination therapy for uncomplicated bacteremia 1.
For Ampicillin-Resistant or Methicillin-Resistant Organisms
- Vancomycin is the drug of choice if E. faecalis is ampicillin-resistant or if S. epidermidis is methicillin-resistant 1, 3.
- Virtually all S. epidermidis isolates are susceptible to vancomycin, and it provides reliable coverage for both organisms 3.
- Vancomycin should be dosed at 30 mg/kg/day IV in 2 divided doses for optimal efficacy 1, 2.
Role of Combination Therapy
- Combination therapy with an aminoglycoside (gentamicin) is NOT necessary for uncomplicated bacteremia without endocarditis 1.
- The role of combination therapy (cell wall-active antimicrobial plus aminoglycoside) for enterococcal catheter-related bloodstream infection without endocarditis remains unresolved 1.
- If catheter salvage is attempted, combination therapy with gentamicin plus ampicillin may be more effective than monotherapy 1.
Treatment Duration and Monitoring
- A 7-14 day course of therapy is recommended for uncomplicated bacteremia when the catheter is removed 1.
- Remove any short-term intravascular catheters immediately 1.
- For long-term catheters, removal is indicated if there is insertion site infection, suppurative thrombophlebitis, sepsis, endocarditis, persistent bacteremia (>72 hours), or metastatic infection 1.
Critical Assessment for Endocarditis
- Obtain transesophageal echocardiography (TEE) if any of the following are present 1:
- New cardiac murmur or embolic phenomena
- Prolonged bacteremia or fever >72 hours despite appropriate antibiotics
- Radiographic evidence of septic pulmonary emboli
- Presence of prosthetic valve or other endovascular foreign bodies
- The risk of endocarditis with enterococcal bacteremia is relatively low (1.5% in one large study), but persistent bacteremia >4 days is independently associated with mortality 1.
- E. faecalis carries higher endocarditis risk than E. faecium 1.
Alternative Regimens for Resistant Organisms
- For ampicillin- and vancomycin-resistant enterococci, use linezolid or daptomycin based on susceptibility results 1.
- Linezolid 600 mg IV/PO every 12 hours is effective against vancomycin-resistant enterococci 4.
- Daptomycin 6 mg/kg/day IV is an alternative, though it may have less prostatic penetration if that is a concern 2, 5.
Common Pitfalls to Avoid
- Do not add gentamicin routinely unless attempting catheter salvage or treating confirmed endocarditis, as it adds nephrotoxicity risk without proven benefit in uncomplicated bacteremia 1.
- Do not assume methicillin susceptibility in S. epidermidis without reliable susceptibility testing, as nosocomial isolates are frequently methicillin-resistant and may appear susceptible unless proper methods are used 3.
- Do not use cephalosporins as monotherapy for this polymicrobial infection, as they lack reliable enterococcal coverage 1.
- Monitor for persistent bacteremia with follow-up blood cultures at 72 hours; persistence mandates catheter removal and extended evaluation for endocarditis 1.